On August 8, 2024, Dabaco Vietnam Group (code: DBC) hosted an investor meeting and organized a visit to some of its production and business facilities in Bac Ninh province. The event was attended by representatives of domestic and foreign professional investment funds interested in agriculture in general and Dabaco in particular.
At the event, Mr. Nguyen Nhu So, Chairman of Dabaco’s Board of Directors, shared insightful information about the livestock, animal feed, and safe food industries. He highlighted that pig farming is one of the key sectors in Vietnam’s agriculture, accounting for approximately 62% of the total output of farmed livestock.
Mr. Nguyen Nhu So, Chairman of the Board of Directors of Dabaco Vietnam Group
It is predicted that Vietnam will rank second in Asia in terms of pork consumption, with a growth rate of 3.1% during the period of 2022-2030. Despite the risks and challenges posed by natural disasters, diseases, and price fluctuations in the agricultural sector, pig farming remains an essential food industry with significant growth potential, both in the domestic market and for exports.
The Group’s leaders also provided investors with an update on the production and business results for the first seven months of the year and shared their plans for the remaining months of 2024. They expressed their commitment to completing the targets entrusted by the shareholders. Dabaco is expediting the investment process and working to quickly put into operation its ongoing projects, including a vaccine factory and a vegetable oil factory in its second phase, ensuring both progress and quality.
During the dialogue session with investors, Dabaco’s leadership team provided specific responses to the investors’ inquiries. The investors highly appreciated the Group’s capabilities and potential. They also had the opportunity to visit the vegetable oil production line and the construction progress of Line 2 at Dabaco Vegetable Oil Company. They also toured Dabaco Group’s vaccine factory, which meets the GMP-WHO standard.
One of the notable investors showing interest in Dabaco recently is the foreign fund Pyn Elite Fund. In their latest report, they acknowledged Dabaco’s significant progress in developing a vaccine for African Swine Fever (ASF), a project in collaboration with US scientists since 2021. Since the beginning of 2024, the vaccine has been administered to 300,000 pigs in Dabaco’s herd with promising results.
With a capacity of 200 million doses per year, the vaccine factory has been completed and received GMP-WHO certification in early August, bringing Dabaco closer to obtaining commercial approval for its vaccines. Pyn Elite Fund is optimistic that the vaccine will not only protect Dabaco’s herd from ASF, a disease that has severely impacted Vietnam’s pig farming industry in recent years, but also significantly boost profits in the coming years.
